Interstitial Lung Disease PBMC
About: Interstitial lung disease PBMC PBMCs collected from interstitial lung disease (ILD) patients, supporting fibrosis and autoimmune lung research.
Interstitial lung disease PBMC
PBMC samples from donors diagnosed with Interstitial lung disease are collected and processed under rigorous standards. These samples support research into alveolar damage and fibrotic remodeling, offering insights into disease mechanisms, biomarker discovery, and therapeutic development.
Product Features
- PBMC isolated from clinically confirmed Interstitial lung disease donors
- Rigorous donor screening and sample quality checks
- Suitable for downstream applications such as flow cytometry, RNA-seq, ELISA, and qPCR
De-identified Donor Data
- Age, sex, race, medication, diagnosis method, disease severity/stage
- Optional: comorbidities, lab values, and clinical history
Applications
- Immunophenotyping
- Transcriptomics & proteomics
- Biomarker validation
- Therapeutic development and screening
Quality and Compliance
- IRB-approved protocols
- Informed donor consent
- Standardized collection and processing SOPs
Ordering & Shipping
Samples are available in both standard and custom volumes to meet your research needs.
International Orders: For international shipments or country-specific documentation requirements, please contact us at learnmore@sanguinebio.com to ensure compliance with your local regulations.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.